ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
TFF Pharmaceuticals Inc

TFF Pharmaceuticals Inc (TFFP)

0,3402
-0,0102
(-2,91%)
Fermé 24 Novembre 10:00PM
0,3099
-0,0303
(-8,91%)
Après les heures de négociation: 1:59AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,3099
Prix Achat
0,30
Prix Vente
0,37
Volume échangé
1 544 731
0,3355 Fourchette du Jour 0,367
0,27 Plage de 52 semaines 11,00
Cap du marché
Clôture Veille
0,3504
Ouverture
0,367
Dernière Transaction
6240
@
0.3099
(formt)
Dernière heure de transaction
Volume financier
US$ 537 412
VWAP
0,3479
Volume moyen (3 m)
1 128 743
Actions en circulation
3 466 041
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,06
Bénéfice par action (BPA)
-6,13
Chiffre d'affairess
734k
Bénéfice net
-21,24M

À propos de TFF Pharmaceuticals Inc

TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
TFF Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TFFP. Le dernier cours de clôture d'TFF Pharmaceuticals était de US$0,35. Au cours de la dernière année, les actions de TFF Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,27 à US$ 11,00.

TFF Pharmaceuticals compte actuellement 3 466 041 actions en circulation. La capitalisation boursière d'TFF Pharmaceuticals est de US$1,21 million. TFF Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.06.

TFFP Dernières nouvelles

TFF Pharmaceuticals Announces It Will Wind Down Operations

FORT WORTH, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has terminated its employees and will wind down its operations...

TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery

FORT WORTH, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on...

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

Partnership funded by BARDA and other US government agencies TFF formulation may provide flexibility of delivery and improve storage and distribution conditions FORT WORTH, Texas, Sept. 11...

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains Ongoing funded work to assess additional influenza strains FORT...

TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FORT WORTH, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

FORTH WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0901-22.5250.40.5350.27122024530.37862497CS
4-1.8601-85.71889400922.173.230.2732596830.48172657CS
12-1.9701-86.40789473682.283.230.2711287430.51638143CS
26-1.9301-86.16517857142.243.230.275454830.57280955CS
52-6.6176-95.52652472036.9275110.273107631.28847602CS
156-189.9401-99.837109067190.252490.2721014835.82219009CS
260-128.1901-99.7588326848128.5528.50.27215455146.88505646CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83,07M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,48M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,59M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
107,47M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
946,09k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
24,39M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
313,51k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
4M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
425,38M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
236,51M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
159,61M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
159,39M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
107,91M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock